UB Paderborn / Katalog / Suche / in CDI

Can the biology of VEGF and haem oxygenases help solve pre-eclampsia?

Biochemical Society transactions, 2009-12, Vol.37 (Pt 6), p.1237

2009

Volltextzugriff (PDF)

The role of heterodimerization between VEGFR-1 and VEGFR-2 in the regulation of endothelial cell homeostasis

Nature communications, 2012-07, Vol.3 (1), p.972-972, Article 972

2012

Volltextzugriff (PDF)

VEGF induces Tie2 shedding via a phosphoinositide 3-kinase/Akt dependent pathway to modulate Tie2 signaling

Arteriosclerosis, thrombosis, and vascular biology, 2007-12, Vol.27 (12), p.2619

2007

Volltextzugriff (PDF)

Resveratrol inhibits the release of soluble fms-like tyrosine kinase (sFlt-1) from human placenta

American journal of obstetrics and gynecology, 2012-03, Vol.206 (3), p.253.e10-253.e15

2012

Volltextzugriff (PDF)

Negative regulation of soluble flt-1 and soluble endoglin release by heme oxygenase-1

Circulation (New York, N.Y.), 2007-04, Vol.115 (13), p.1789-1797

2007

Volltextzugriff (PDF)

Flt1 acts as a negative regulator of tip cell formation and branching morphogenesis in the zebrafish embryo

Development (Cambridge), 2011-05, Vol.138 (10), p.2111-2120

2011

Volltextzugriff (PDF)

Reduction of circulating soluble Flt‐1 alleviates preeclampsia‐like symptoms in a mouse model

Journal of cellular and molecular medicine, 2010-06, Vol.14 (6b), p.1857-1867

2010

Volltextzugriff (PDF)

Loss of Akt activity increases circulating soluble endoglin release in preeclampsia: identification of inter-dependency between Akt-1 and heme oxygenase-1

European heart journal, 2012-05, Vol.33 (9), p.1150-1158

2012

Volltextzugriff (PDF)

Activation of Proteinase-Activated Receptor 2 Stimulates Soluble Vascular Endothelial Growth Factor Receptor 1 Release via Epidermal Growth Factor Receptor Transactivation in Endothelial Cells

Hypertension (Dallas, Tex. 1979), 2010-03, Vol.55 (3), p.689-697

2010

Volltextzugriff (PDF)

Direct Evidence for Endothelial Vascular Endothelial Growth Factor Receptor-1 Function in Nitric Oxide–Mediated Angiogenesis

Circulation research, 2006-09, Vol.99 (7), p.715-722

2006

Volltextzugriff (PDF)

Upregulation of Urotensin II Receptor in Preeclampsia Causes In Vitro Placental Release of Soluble Vascular Endothelial Growth Factor Receptor 1 in Hypoxia

Hypertension (Dallas, Tex. 1979), 2010-07, Vol.56 (1), p.172-178

2010

Volltextzugriff (PDF)

Autocrine activity of soluble Flt-1 controls endothelial cell function and angiogenesis

Vascular cell, 2011-07, Vol.3 (1), p.15-15

2011

Volltextzugriff (PDF)

Angiopoietin-1 Induces Migration of Monocytes in a Tie-2 and Integrin-Independent Manner

Hypertension (Dallas, Tex. 1979), 2010-09, Vol.56 (3), p.477-483

2010

Volltextzugriff (PDF)

VEGF-E activates endothelial nitric oxide synthase to induce angiogenesis via cGMP and PKG-independent pathways

Biochemical and biophysical research communications, 2006-07, Vol.345 (4), p.1275-1282

2006

Volltextzugriff (PDF)

The release of nitric oxide from S-nitrosothiols promotes angiogenesis

PloS one, 2006-12, Vol.1 (1), p.e25-e25

2006

Volltextzugriff (PDF)

Dysregulation of Hydrogen Sulfide Producing Enzyme Cystathionine γ-lyase Contributes to Maternal Hypertension and Placental Abnormalities in Preeclampsia

Circulation (New York, N.Y.), 2013-06, Vol.127 (25), p.2514-2522

2013

Volltextzugriff (PDF)

Pravastatin for early‐onset pre‐eclampsia: a randomised, blinded, placebo‐controlled trial

BJOG : an international journal of obstetrics and gynaecology, 2020-03, Vol.127 (4), p.478-488

2020

Volltextzugriff (PDF)

Carbon monoxide inhibits sprouting angiogenesis and vascular endothelial growth factor receptor-2 phosphorylation

Thrombosis and haemostasis, 2015-02, Vol.113 (2), p.329

2015

Volltextzugriff (PDF)

Placental Morphology Is Associated with Maternal Depressive Symptoms during Pregnancy and Toddler Psychiatric Problems

Scientific reports, 2018-01, Vol.8 (1), p.791-12, Article 791

2018

Volltextzugriff (PDF)

Angiopoietin-2 Confers Atheroprotection in apoE−/− Mice by Inhibiting LDL Oxidation via Nitric Oxide

Circulation research, 2009-06, Vol.104 (12), p.1333-1336

2009

Volltextzugriff (PDF)

Response to Letter Regarding Article, “Dysregulation of Hydrogen Sulfide (H2S) Producing Enzyme Cystathionine γ-lyase (CSE) Contributes to Maternal Hypertension and Placental Abnormalities in Preeclampsia”

Circulation (New York, N.Y.), 2014-06, Vol.129 (22), p.e517-e518

2014

Volltextzugriff (PDF)

The role of heterodimerisation between VEGFR-1 and VEGFR-2 in the regulation of vasculogenesis, angiogenesis and endothelial cell homeostasis, MRC

Impact, 2017-08 (6), p.61-63

Cudmore, Melissa

2017

Volltextzugriff (PDF)

Flt1 acts as a negative regulator of tip cell formation and branching morphogenesis in the zebrafish embryo

Journal of cell science, 2011-05, Vol.124 (10), p.e1-e1

2011

Volltextzugriff (PDF)

Angiopoietin-2 Confers Atheroprotection in apsE―/― Mice by Inhibiting LDL Oxidation via Nitric Oxide

Circulation research, 2009, Vol.104 (12), p.1333-1336

2009

Volltextzugriff (PDF)

Activation of endothelial VEGFR-2 stimulates release of SFLT-1 via a phosphoinositide 3-kinase/protein kinase c? Dependent and AKT-independent pathway

Vascular pharmacology, 2006-09, Vol.45 (3), p.e139-e140

2006

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Can the biology of VEGF and haem oxygenases help solve pre-eclampsia?

The role of heterodimerization between VEGFR-1 and VEGFR-2 in the regulation of endothelial cell homeostasis

VEGF induces Tie2 shedding via a phosphoinositide 3-kinase/Akt dependent pathway to modulate Tie2 signaling

Resveratrol inhibits the release of soluble fms-like tyrosine kinase (sFlt-1) from human placenta

Negative regulation of soluble flt-1 and soluble endoglin release by heme oxygenase-1

Flt1 acts as a negative regulator of tip cell formation and branching morphogenesis in the zebrafish embryo

Reduction of circulating soluble Flt‐1 alleviates preeclampsia‐like symptoms in a mouse model

Loss of Akt activity increases circulating soluble endoglin release in preeclampsia: identification of inter-dependency between Akt-1 and heme oxygenase-1

Activation of Proteinase-Activated Receptor 2 Stimulates Soluble Vascular Endothelial Growth Factor Receptor 1 Release via Epidermal Growth Factor Receptor Transactivation in Endothelial Cells

Direct Evidence for Endothelial Vascular Endothelial Growth Factor Receptor-1 Function in Nitric Oxide–Mediated Angiogenesis

Upregulation of Urotensin II Receptor in Preeclampsia Causes In Vitro Placental Release of Soluble Vascular Endothelial Growth Factor Receptor 1 in Hypoxia

Autocrine activity of soluble Flt-1 controls endothelial cell function and angiogenesis

Angiopoietin-1 Induces Migration of Monocytes in a Tie-2 and Integrin-Independent Manner

VEGF-E activates endothelial nitric oxide synthase to induce angiogenesis via cGMP and PKG-independent pathways

The release of nitric oxide from S-nitrosothiols promotes angiogenesis

Dysregulation of Hydrogen Sulfide Producing Enzyme Cystathionine γ-lyase Contributes to Maternal Hypertension and Placental Abnormalities in Preeclampsia

Pravastatin for early‐onset pre‐eclampsia: a randomised, blinded, placebo‐controlled trial

Carbon monoxide inhibits sprouting angiogenesis and vascular endothelial growth factor receptor-2 phosphorylation

Placental Morphology Is Associated with Maternal Depressive Symptoms during Pregnancy and Toddler Psychiatric Problems

Angiopoietin-2 Confers Atheroprotection in apoE−/− Mice by Inhibiting LDL Oxidation via Nitric Oxide

Response to Letter Regarding Article, “Dysregulation of Hydrogen Sulfide (H2S) Producing Enzyme Cystathionine γ-lyase (CSE) Contributes to Maternal Hypertension and Placental Abnormalities in Preeclampsia”

The role of heterodimerisation between VEGFR-1 and VEGFR-2 in the regulation of vasculogenesis, angiogenesis and endothelial cell homeostasis, MRC

Flt1 acts as a negative regulator of tip cell formation and branching morphogenesis in the zebrafish embryo

Angiopoietin-2 Confers Atheroprotection in apsE―/― Mice by Inhibiting LDL Oxidation via Nitric Oxide

Activation of endothelial VEGFR-2 stimulates release of SFLT-1 via a phosphoinositide 3-kinase/protein kinase c? Dependent and AKT-independent pathway

Suchergebnisse filtern